1. Pharmaceutical cGMPs for the 21st Century - A Risk-Based Approach.Final Report.Department of Health and Human Services, U.S. Food and Drug Administration:Washington, D.C., Fall (September) 2004; seehttp://www.fda.gov/cder/gmp/gmp2004/GMP_finalreport2004.htm.
2. SeeICH Guidelines Q8, Annex to Q8, and Q9; Available online at:http://www.ich.org/cache/compo/363-272-1.html.
3. Guidance for Industry: PAT - A Framework for Innovative Pharmaceutical Development, Manufacturing, and Quality Assurance.Department of Health and Human Services, U.S. Food and Drug Administration:Washington, D.C., September 2005. Seehttp://www.fda.gov/cder/guidance/6419fnl.pdf.